Furthermore, the Authority could not carry out a complete consumer risk assessment because neither all commodities nor all potentially relevant metabolites could be assessed based on the information provided by the applicant. Lastly, the Authority concluded that the assessment of developmental neurotoxicity could not be finalised since no appropriate study was submitted by the applicant.
Recital 9, Regulation (EU) 2022/94
In forcesince 24 Jan 2022